Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.35 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5441435 | 0.79 | HTT (0.49) | HTTNPSR1L3MBTL1SIGMAR1CYP2A6 | |
| SCHEMBL13338451 | 0.79 | KDM4E (0.39) | EGFRHTTNPSR1L3MBTL1KDM4E | |
| SCHEMBL27634836 | 0.78 | ALDH1A1 (0.41) | EGFRHTTNPSR1L3MBTL1KDM4E | |
| SCHEMBL795930 | 0.77 | EGFR (0.46) | EGFRHTTL3MBTL1 | |
| SCHEMBL13367500 | 0.75 | MAPK1 (0.40) | EGFRL3MBTL1KDM4ETDP1NPC1 | |
| SCHEMBL16920398 | 0.75 | CHRM5 (0.43) | HTTNPSR1L3MBTL1DOT1LKDM4E | |
| SCHEMBL29619639 | 0.74 | NPSR1 (0.45) | HTTNPSR1L3MBTL1KDM4ESIGMAR1 | |
| SCHEMBL844507 | 0.74 | NPSR1 (0.45) | HTTNPSR1L3MBTL1KDM4ESIGMAR1 | |
| SCHEMBL25812224 | 0.73 | ALDH1A1 (0.44) | HTTNPSR1L3MBTL1DOT1LSIGMAR1 | |
| SCHEMBL13367447 | 0.72 | DOT1L (0.44) | HTTNPSR1L3MBTL1DOT1LKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OR10J3, OCIAD1, OCIAD2 | EGFR 1659/4885HTT 2003/4885NPSR1 3333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.